Laboratory and echocardiographic characteristics of patients with HIV infection (groups I and II) and controls (group III)
| Variables | HIV infection (n = 49) | Controls (n = 58) | p value |
|---|---|---|---|
| LVEDD > 5.5 cm (% (n)) | 24.4% (12) | 3.5% (2) | < 0.001 |
| Septal wall thickness (cm)2-150 | 1.3 (0.3) | 0.9 (0.2) | < 0.001 |
| Left atrial diameter (cm) | 3.1 (0.5) | 3 (0.4) | NS |
| LV wall thickness (cm)2-150 | 1.33 (0.4) | 1 (0.3) | < 0.05 |
| VE (m/s) | 0.51 (0.1) | 0.84 (0.1) | < 0.001 |
| VA (m/s) | 0.64 (0.1) | 0.58 (0.1) | < 0.05 |
| Diastolic dysfunction | 85.7% | 13.8% | < 0.001 |
| (n = 42) | (n = 8) | ||
| Concentric LV hypertrophy | 46.9% | 6.9% | < 0.001 |
| (n = 23) | (n = 4) | ||
| Haemoglobin (g/l) | 104 (12) | 134 (16) | < 0.05 |
| ESR (mm in 1st hour) | 39.2 (5.0) | 25.0 (4.0) | < 0.05 |
| CD4+ count (/mm3) | 233 (57) | 1043 (112) | < 0.001 |
Values are mean (SD) except where specified.
↵2-150 In diastole.
ESR, erythrocyte sedimentation rate; LV, left ventricular; LVEDD, left ventricular end diastolic diameter; VA, peak late velocity; VE, peak early diastolic velocity.